These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 228513)

  • 1. [Passive protection tests in the mouse with pertussis immunoglobulin (author's transl)].
    Sabin S; Schwanig M
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):268-74. PubMed ID: 228513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Duration of efficiency of pertussis immunoglobulin in the passive protection tests in mice (author's transl)].
    Sabin S; Schwanig M; Schneider W
    Zentralbl Bakteriol A; 1981; 249(2):254-60. PubMed ID: 6267844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency testing of pertussis immunoglobulins, relationship between neutralisation test and agglutination test.
    Schneider W; Sabin S; Schwanig M
    Dev Biol Stand; 1979; 44():125-8. PubMed ID: 575633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.
    van der Ark A; van Straaten-van de Kappelle I; Olander RM; Enssle K; Jadhav S; van de Donk H; Hendriksen C
    Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid and simple method for evaluation of serum opsonic capacity against Bordetella pertussis by chemiluminescence.
    Lilius EM; Mertsola J; Leivo P; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():373-7. PubMed ID: 2872125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B. pertussis in Czechoslovakia in the years 1966-1970.
    Maixnerová M; Burianová-Vysoká B; Stránský V
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):267-72. PubMed ID: 4342922
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB; Wilson JV; Habel H; Blaskett A
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity.
    Mills KH; Brady M; Ryan E; Mahon BP
    Dev Biol Stand; 1998; 95():31-41. PubMed ID: 9855412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the usefulness of Bordetella pertussis toxins for serodiagnosis of whooping cough].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 1998; 50(1-2):89-95. PubMed ID: 9857618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.
    Giammanco A; Nardone A; Pebody R; Kafatos G; Andrews N; Chiarini A; Taormina S; de Ory F; Prosenc K; Krize B; Hallander H; Ljungman M; Marva E; Tsakris A; O'Flanagan D; Schneider F; Griskevicius A; Vranckx R; Karacs I
    Vaccine; 2008 Aug; 26(35):4486-93. PubMed ID: 18602434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.